{"gene":"EXOSC2","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1997,"finding":"EXOSC2 (hRrp4/Rrp4p) was identified as a core component of the eukaryotic RNA exosome, a conserved multisubunit complex. Yeast Rrp4p (the ortholog of human EXOSC2) was shown to be an essential 3'→5' exoribonuclease required for 3' processing of 5.8S rRNA. Recombinant Rrp4p exhibited distributive 3'→5' exoribonuclease activity in vitro, and human hRRP4 was found in a comparably sized complex to the yeast exosome, with expression of hRRP4 complementing the yeast rrp4-1 mutation.","method":"Biochemical purification, in vitro exoribonuclease assay, genetic complementation (hRRP4 rescuing yeast rrp4-1)","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic reconstitution plus genetic complementation, foundational discovery paper with >800 citations","pmids":["9390555"],"is_preprint":false},{"year":1999,"finding":"The human homolog of yeast Rrp4p (EXOSC2) was confirmed as a component of the human PM-Scl complex (equivalent to the yeast exosome). The human exosome exists in distinct nuclear and cytoplasmic forms; the nuclear form uniquely contains Rrp6p/PM-Scl100. Human Rrp4p (EXOSC2) was shown to complement the yeast rrp4 mutation, establishing functional conservation. The complex contains multiple predicted 3'→5' exoribonucleases.","method":"Biochemical fractionation, indirect immunofluorescence, genetic complementation, sequence homology analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 — complementation plus biochemical fractionation plus localization, replicated across yeast and human systems","pmids":["10465791"],"is_preprint":false},{"year":2001,"finding":"The human RNA exosome (containing EXOSC2/hRrp4 as a core subunit) was purified by mass spectrometry and shown to be required for rapid degradation of ARE-containing mRNAs in a cell-free RNA decay system. The exosome does not recognize ARE-containing RNAs autonomously; ARE-binding proteins (such as KSRP) interact with the exosome and recruit it to unstable target mRNAs.","method":"Affinity purification/mass spectrometry of human exosome, cell-free RNA decay assay, immunodepletion","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — cell-free reconstitution of decay activity with immunodepletion controls, multiple orthogonal methods","pmids":["11719186"],"is_preprint":false},{"year":2005,"finding":"The ARE-binding proteins TTP and BRF-1 recruit the RNA exosome (which contains EXOSC2 as a core subunit) to ARE-containing mRNAs via two distinct activation domains. The N-terminal activation domain of TTP functions as a binding platform for mRNA decay enzymes including the exosome, linking ARE-mRNAs to 3'→5' exonucleolytic decay.","method":"Co-immunoprecipitation, tethering assays with heterologous RNA-binding domain fusions, dominant-negative overexpression","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interactions confirmed with multiple functional assays and dominant-negative validation","pmids":["15687258"],"is_preprint":false},{"year":2006,"finding":"The 9-subunit human RNA exosome (including EXOSC2/hRrp4) was reconstituted recombinantly and its X-ray crystal structure was determined at 3.35 Å resolution. Human Rrp41/Rrp45 heterodimer displayed processive phosphorolytic 3'→5' exoribonuclease activity, while the intact 9-subunit human exosome also showed processive phosphorolytic activity on AU-rich, poly(A), and generic RNA substrates. The structure revealed the conserved barrel-like architecture with EXOSC2 (Rrp4) as a cap subunit on the ring.","method":"Recombinant protein reconstitution, X-ray crystallography (3.35 Å), in vitro exoribonuclease assay with multiple RNA substrates","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus reconstituted biochemical activity with comparative analysis across multiple subunit compositions","pmids":["17174896"],"is_preprint":false},{"year":2005,"finding":"EXOSC2 (hRrp4) was detected as part of the nucleolar proteome in human cells and was shown to flux out of the nucleolus in response to metabolic inhibitors (actinomycin D, 5-fluorouridine, RNase inhibitor), consistent with a role in nucleolar RNA processing. The exosome components including EXOSC2 exit the nucleolus with similar kinetics, indicating stable complex association.","method":"SILAC-based quantitative mass spectrometry of nucleolar proteome, in vivo fluorescent protein imaging, metabolic inhibitor treatment","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative proteomics with functional perturbation, but localization study without direct mechanistic follow-up for EXOSC2 specifically","pmids":["15635413"],"is_preprint":false},{"year":2008,"finding":"The archaeal exosome cap subunit Rrp4 (ortholog of human EXOSC2) from Sulfolobus solfataricus is required for efficient RNA degradation but not for polyadenylation by the hexameric catalytic ring. The Rrp4-containing exosome (versus the hexamer alone) enables efficient phosphorolytic degradation of substrates that the hexamer cannot efficiently process alone, demonstrating that the RNA-binding cap confers substrate accessibility to the catalytic core.","method":"In vitro reconstitution of archaeal exosome subcomplexes, RNA degradation and polyadenylation assays with varied substrates and conditions","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with multiple substrate types and systematic comparison of subunit compositions","pmids":["19053279"],"is_preprint":false},{"year":2010,"finding":"The archaeal Rrp4-containing exosome (ortholog of EXOSC2) confers a strong preference for poly(A) RNA substrates, whereas the Csl4-containing exosome prefers A-poor 3'-ends. This demonstrates that the two cap subunits (Rrp4 and Csl4) impart distinct substrate specificities to the same catalytic ring, establishing that EXOSC2/Rrp4 specifically promotes processing of polyadenylated RNA targets.","method":"In vitro RNA processing assays with reconstituted archaeal exosome subcomplexes containing either Rrp4 or Csl4, using poly(A), polyU, and heteropolymeric RNA substrates","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with defined subunit compositions and systematic substrate variation","pmids":["20488184"],"is_preprint":false},{"year":2016,"finding":"Biallelic missense mutations in EXOSC2 (encoding the RRP4 cap subunit of the RNA exosome) cause a novel human Mendelian syndrome (SHRF) characterized by retinitis pigmentosa, progressive sensorineural hearing loss, premature ageing, short stature, brachydactyly, and mild intellectual disability. Three patients from two unrelated families carried homozygous or compound heterozygous EXOSC2 missense variants, implicating altered RNA exosome function in the pathogenesis and demonstrating tissue-specific consequences distinct from other exosome subunit diseases (EXOSC3, EXOSC8).","method":"Whole exome sequencing, clinical ascertainment of three affected individuals from two unrelated families","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 3 — genetic identification of pathogenic variants without direct molecular mechanism characterization in this paper","pmids":["26843489"],"is_preprint":false},{"year":2020,"finding":"The SHRF-associated pathogenic G198D mutation in EXOSC2 prevents binding to other RNA exosome components, resulting in protein and complex instability. Patient-derived lymphoblasts and CRISPR-generated mutant fetal keratinocytes showed altered expression/activities of critical genes including those in the autophagy pathway. In Drosophila, the fly rrp4 ortholog was shown to be essential; fly rrp4 phenotypes (small eye, adult lethality) could be rescued by wild-type human EXOSC2 but not the G198D pathogenic form. Overexpression of MITF transcription factor, or the autophagy genes ATG1 and ATG17 (regulated by MITF), rescued rrp4 inhibition phenotypes. Pharmacological stimulation of autophagy with rapamycin also rescued lethality caused by rrp4 inactivation.","method":"Patient-derived lymphoblast analysis, CRISPR knockout in fetal keratinocytes, Drosophila genetics (PBac transposon, RNAi, CRISPR KO), cross-species rescue experiments, rapamycin pharmacological rescue","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including cross-species genetic rescue, pathogenic mutation functional validation, and pharmacological rescue converging on autophagy pathway","pmids":["31628467"],"is_preprint":false}],"current_model":"EXOSC2 (hRrp4) functions as an essential cap subunit of the RNA exosome, a conserved multisubunit 3'→5' exoribonuclease complex; it confers substrate specificity (preferentially enabling processing of polyadenylated RNAs) to the catalytic ring, is required for 5.8S rRNA 3'-processing and ARE-mediated mRNA decay (via recruitment by ARE-binding proteins such as TTP), localizes to both nuclear/nucleolar and cytoplasmic exosome pools, and its pathogenic missense mutations (e.g., G198D causing SHRF syndrome) disrupt binding to other exosome subunits leading to complex instability and defective autophagy pathway regulation."},"narrative":{"teleology":[{"year":1997,"claim":"The discovery that Rrp4p is an essential 3'→5' exoribonuclease subunit of the yeast exosome complex — and that human EXOSC2 complements the yeast mutation — established the conserved role of this gene in RNA processing and defined the exosome as a multisubunit degradation machine.","evidence":"Biochemical purification, in vitro exoribonuclease assay, and cross-species genetic complementation in yeast","pmids":["9390555"],"confidence":"High","gaps":["Whether EXOSC2 itself contributes catalytic activity or solely serves a structural/substrate-channeling role in the human complex was unresolved","Identity of in vivo RNA substrates beyond 5.8S rRNA unknown"]},{"year":1999,"claim":"Demonstration that the human exosome exists in distinct nuclear and cytoplasmic pools, with EXOSC2 present in both, revealed compartment-specific functions and linked the complex to the PM-Scl autoantigen.","evidence":"Biochemical fractionation and indirect immunofluorescence in human cells","pmids":["10465791"],"confidence":"High","gaps":["Whether EXOSC2 has compartment-specific roles beyond shared core membership was not addressed","Mechanism of nuclear versus cytoplasmic sorting of exosome subcomplexes undefined"]},{"year":2001,"claim":"The finding that the human exosome is required for ARE-mediated mRNA decay — recruited by ARE-binding proteins rather than recognizing substrates autonomously — placed EXOSC2-containing complexes at the center of regulated mRNA turnover.","evidence":"Affinity-purified human exosome tested in cell-free ARE-RNA decay assay with immunodepletion controls","pmids":["11719186"],"confidence":"High","gaps":["Direct contact between EXOSC2 and ARE-binding adaptors was not mapped","Relative contributions of individual cap subunits to adaptor recruitment unknown"]},{"year":2005,"claim":"Identification of TTP and BRF-1 activation domains as direct exosome-recruiting interfaces provided a molecular mechanism for how ARE-containing mRNAs are coupled to 3'→5' exonucleolytic decay via the EXOSC2-containing complex.","evidence":"Co-immunoprecipitation and tethering assays with heterologous RNA-binding domain fusions, dominant-negative overexpression","pmids":["15687258"],"confidence":"High","gaps":["Whether EXOSC2 is the direct binding partner for TTP/BRF-1 or whether another subunit mediates the interaction was not determined"]},{"year":2006,"claim":"The crystal structure of the reconstituted 9-subunit human exosome at 3.35 Å resolution revealed the barrel-like architecture with EXOSC2 as a cap subunit and demonstrated processive phosphorolytic activity of the ring, resolving the structural framework for substrate channeling.","evidence":"Recombinant reconstitution and X-ray crystallography of the human exosome complex","pmids":["17174896"],"confidence":"High","gaps":["Structure did not resolve how RNA threads through the cap into the catalytic channel at high resolution","Human-specific regulatory contacts of EXOSC2 not detailed"]},{"year":2010,"claim":"Reconstitution of archaeal exosomes containing either Rrp4 or Csl4 cap subunits showed that the Rrp4 cap (EXOSC2 ortholog) confers a strong preference for poly(A) substrates, establishing that individual cap subunits dictate substrate specificity of the catalytic ring.","evidence":"In vitro RNA processing assays with defined archaeal exosome subcomplexes and systematic substrate variation","pmids":["20488184"],"confidence":"High","gaps":["Whether the poly(A) preference of Rrp4/EXOSC2 is conserved in the eukaryotic 9-subunit context was not directly tested","Structural basis of poly(A) selectivity at the Rrp4 S1/KH domains unresolved"]},{"year":2016,"claim":"Whole-exome sequencing linked biallelic EXOSC2 missense mutations to SHRF syndrome, a previously unrecognized Mendelian disorder, demonstrating that partial loss of this exosome cap subunit produces tissue-specific pathology distinct from diseases caused by mutations in other exosome subunits.","evidence":"Whole-exome sequencing in three patients from two unrelated families","pmids":["26843489"],"confidence":"Medium","gaps":["Molecular mechanism by which the mutations compromise exosome function was not characterized in this study","Why EXOSC2 mutations produce a different clinical spectrum than EXOSC3/EXOSC8 mutations remained unexplained"]},{"year":2020,"claim":"Functional characterization of the SHRF-associated G198D mutation revealed that it disrupts EXOSC2 binding to other exosome subunits, destabilizes the complex, and deregulates autophagy-related gene expression; pharmacological or genetic restoration of autophagy rescued loss-of-function phenotypes, identifying autophagy as a critical downstream effector of exosome integrity.","evidence":"Patient lymphoblasts, CRISPR mutant keratinocytes, Drosophila cross-species rescue experiments, and rapamycin pharmacological rescue","pmids":["31628467"],"confidence":"High","gaps":["Whether autophagy deregulation is a direct consequence of specific RNA misprocessing or a secondary stress response is unclear","The EXOSC2-dependent RNA targets whose misprocessing drives the SHRF phenotype have not been identified transcriptome-wide","Whether rapamycin-based autophagy stimulation is a viable therapeutic strategy in SHRF patients is untested"]},{"year":null,"claim":"Key unresolved questions include the identity of specific RNA substrates whose processing depends on the EXOSC2 cap (versus the EXOSC1/Csl4 cap) in human cells, the structural basis for poly(A) selectivity by the EXOSC2 S1/KH domains in the eukaryotic context, and why EXOSC2 mutations produce a tissue-specific disease spectrum (retina, cochlea, skeleton) despite the exosome's ubiquitous expression.","evidence":"","pmids":[],"confidence":"Low","gaps":["No transcriptome-wide identification of EXOSC2-cap-dependent versus EXOSC1-cap-dependent substrates in human cells","No high-resolution structure of EXOSC2 with RNA threaded through the channel in the eukaryotic context","Tissue-specific vulnerability mechanism for SHRF syndrome unexplained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,4,6,7]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,6,7]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[1,5]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,5]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,2,3,6,7]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[9]}],"complexes":["RNA exosome"],"partners":["EXOSC4","EXOSC7","TTP","KSRP","BRF1"],"other_free_text":[]},"mechanistic_narrative":"EXOSC2 (RRP4) is an essential cap subunit of the RNA exosome, a conserved multisubunit 3'→5' exoribonuclease complex that mediates processing and degradation of diverse RNA substrates. EXOSC2 sits atop the hexameric catalytic ring and confers substrate specificity, preferentially directing the complex toward polyadenylated RNA targets, while also enabling efficient substrate access to the catalytic core for phosphorolytic degradation [PMID:9390555, PMID:17174896, PMID:20488184]. The exosome containing EXOSC2 is recruited to AU-rich element (ARE)-containing mRNAs by RNA-binding proteins such as TTP and KSRP, coupling it to rapid cytoplasmic mRNA turnover, and it functions in nucleolar 5.8S rRNA 3'-end processing [PMID:11719186, PMID:15687258, PMID:15635413]. Biallelic missense mutations in EXOSC2 cause SHRF syndrome (retinitis pigmentosa, hearing loss, premature ageing, short stature, brachydactyly, and mild intellectual disability); the pathogenic G198D variant disrupts exosome subunit binding, destabilizes the complex, and deregulates autophagy, with autophagy stimulation rescuing loss-of-function phenotypes in Drosophila [PMID:26843489, PMID:31628467]."},"prefetch_data":{"uniprot":{"accession":"Q13868","full_name":"Exosome complex component RRP4","aliases":["Exosome component 2","Ribosomal RNA-processing protein 4"],"length_aa":293,"mass_kda":32.8,"function":"Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC2 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC4 and EXOSC7","subcellular_location":"Cytoplasm; Nucleus, nucleolus; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13868/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/EXOSC2","classification":"Common Essential","n_dependent_lines":1185,"n_total_lines":1208,"dependency_fraction":0.9809602649006622},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DRG1","stoichiometry":0.2},{"gene":"G3BP2","stoichiometry":0.2},{"gene":"NPM1","stoichiometry":0.2},{"gene":"PSPC1","stoichiometry":0.2},{"gene":"RACK1","stoichiometry":0.2},{"gene":"RBM7","stoichiometry":0.2},{"gene":"RPS16","stoichiometry":0.2},{"gene":"SFPQ","stoichiometry":0.2},{"gene":"SRP9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/EXOSC2","total_profiled":1310},"omim":[{"mim_id":"617763","title":"SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF","url":"https://www.omim.org/entry/617763"},{"mim_id":"614183","title":"DIS3-LIKE EXOSOME 3-PRIME-5-PRIME EXORIBONUCLEASE; DIS3L","url":"https://www.omim.org/entry/614183"},{"mim_id":"602238","title":"EXOSOME COMPONENT 2; EXOSC2","url":"https://www.omim.org/entry/602238"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/EXOSC2"},"hgnc":{"alias_symbol":["hRrp4p","Rrp4p","RRP4","p7"],"prev_symbol":[]},"alphafold":{"accession":"Q13868","domains":[{"cath_id":"2.40.50.100","chopping":"25-70","consensus_level":"high","plddt":88.2417,"start":25,"end":70}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13868","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13868-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13868-F1-predicted_aligned_error_v6.png","plddt_mean":81.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EXOSC2","jax_strain_url":"https://www.jax.org/strain/search?query=EXOSC2"},"sequence":{"accession":"Q13868","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13868.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13868/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13868"}},"corpus_meta":[{"pmid":"12560074","id":"PMC_12560074","title":"The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12560074","citation_count":355,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17537845","id":"PMC_17537845","title":"Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.","date":"2007","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17537845","citation_count":352,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7518529","id":"PMC_7518529","title":"Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini.","date":"1994","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/7518529","citation_count":304,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12719519","id":"PMC_12719519","title":"The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12719519","citation_count":279,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17658949","id":"PMC_17658949","title":"Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions.","date":"2007","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/17658949","citation_count":277,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17079282","id":"PMC_17079282","title":"Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17079282","citation_count":245,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23739335","id":"PMC_23739335","title":"Unusual architecture of the p7 channel from hepatitis C virus.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23739335","citation_count":222,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14504405","id":"PMC_14504405","title":"The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14504405","citation_count":178,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9751708","id":"PMC_9751708","title":"Reactivity of the HIV-1 nucleocapsid protein p7 zinc finger domains from the perspective of density-functional theory.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9751708","citation_count":172,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11907211","id":"PMC_11907211","title":"Subcellular localization and topology of the p7 polypeptide of hepatitis C virus.","date":"2002","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11907211","citation_count":161,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20824094","id":"PMC_20824094","title":"Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/20824094","citation_count":143,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14769903","id":"PMC_14769903","title":"A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.","date":"2004","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/14769903","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11000219","id":"PMC_11000219","title":"E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies.","date":"2000","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11000219","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8648755","id":"PMC_8648755","title":"Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7.","date":"1996","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/8648755","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10471445","id":"PMC_10471445","title":"Inflammatory responses in the cerebral cortex after ischemia in the P7 neonatal Rat.","date":"1999","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/10471445","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17032656","id":"PMC_17032656","title":"Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17032656","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20667830","id":"PMC_20667830","title":"NMR structure and ion channel activity of the p7 protein from hepatitis C virus.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20667830","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10957718","id":"PMC_10957718","title":"Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.","date":"2000","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/10957718","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18828153","id":"PMC_18828153","title":"Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.","date":"2008","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/18828153","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23658526","id":"PMC_23658526","title":"hepatitis c Virus p7 is critical for capsid assembly and envelopment.","date":"2013","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/23658526","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16420050","id":"PMC_16420050","title":"Protein-protein interactions: modeling the hepatitis C virus ion channel p7.","date":"2006","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16420050","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1959614","id":"PMC_1959614","title":"Structural characterization of a 39-residue synthetic peptide containing the two zinc binding domains from the HIV-1 p7 nucleocapsid protein by CD and NMR spectroscopy.","date":"1991","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/1959614","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20885952","id":"PMC_20885952","title":"Genomic analysis of carbon monoxide utilization and butanol production by Clostridium carboxidivorans strain P7.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20885952","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10074407","id":"PMC_10074407","title":"Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10074407","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9774351","id":"PMC_9774351","title":"Probing the structure of complex macromolecular interactions by homolog specificity scanning: the P1 and P7 plasmid partition systems.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9774351","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26843489","id":"PMC_26843489","title":"Mutations in EXOSC2 are associated with a novel syndrome characterised by retinitis pigmentosa, progressive hearing loss, premature ageing, short stature, mild intellectual disability and distinctive gestalt.","date":"2016","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26843489","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20156486","id":"PMC_20156486","title":"A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues.","date":"2010","source":"Antiviral research","url":"https://pubmed.ncbi.nlm.nih.gov/20156486","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21671041","id":"PMC_21671041","title":"The P7-1 protein of southern rice black-streaked dwarf virus, a fijivirus, induces the formation of tubular structures in insect cells.","date":"2011","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/21671041","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7597035","id":"PMC_7597035","title":"Precursor of C4 antisense RNA of bacteriophages P1 and P7 is a substrate for RNase P of Escherichia coli.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7597035","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19726506","id":"PMC_19726506","title":"Characterization of determinants important for hepatitis C virus p7 function in morphogenesis by using trans-complementation.","date":"2009","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19726506","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16306623","id":"PMC_16306623","title":"Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes.","date":"2005","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/16306623","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8170387","id":"PMC_8170387","title":"The homologous operons for P1 and P7 plasmid partition are autoregulated from dissimilar operator sites.","date":"1994","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/8170387","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19461582","id":"PMC_19461582","title":"Structural basis for ADP-mediated transcriptional regulation by P1 and P7 ParA.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19461582","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19493992","id":"PMC_19493992","title":"Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.","date":"2009","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19493992","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2585492","id":"PMC_2585492","title":"Plasmid-partition functions of the P7 prophage.","date":"1989","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2585492","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22496228","id":"PMC_22496228","title":"Classical swine fever virus p7 protein is a viroporin involved in virulence in swine.","date":"2012","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/22496228","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17302250","id":"PMC_17302250","title":"Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.","date":"2006","source":"Antiviral therapy","url":"https://pubmed.ncbi.nlm.nih.gov/17302250","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19406216","id":"PMC_19406216","title":"Post-ischemic hypothermia for 24h in P7 rats rescues hippocampal neuron: association with decreased astrocyte activation and inflammatory cytokine expression.","date":"2009","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/19406216","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15247249","id":"PMC_15247249","title":"Regulation of hepatitis C virus polyprotein processing by signal peptidase involves structural determinants at the p7 sequence junctions.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15247249","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23028296","id":"PMC_23028296","title":"The p7 protein of hepatitis C virus forms structurally plastic, minimalist ion channels.","date":"2012","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/23028296","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19727701","id":"PMC_19727701","title":"NMR studies of p7 protein from hepatitis C virus.","date":"2009","source":"European biophysics journal : EBJ","url":"https://pubmed.ncbi.nlm.nih.gov/19727701","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20727850","id":"PMC_20727850","title":"Secondary structure, dynamics, and architecture of the p7 membrane protein from hepatitis C virus by NMR spectroscopy.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20727850","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7669337","id":"PMC_7669337","title":"The tripartite immunity system of phages P1 and P7.","date":"1995","source":"FEMS microbiology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/7669337","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23841474","id":"PMC_23841474","title":"Three-dimensional structure and interaction studies of hepatitis C virus p7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine by solution nuclear magnetic resonance.","date":"2013","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23841474","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36706489","id":"PMC_36706489","title":"Biodegradation of polyester polyurethane by Cladosporium sp. P7: Evaluating its degradation capacity and metabolic pathways.","date":"2023","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/36706489","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1696181","id":"PMC_1696181","title":"The c4 repressors of bacteriophages P1 and P7 are antisense RNAs.","date":"1990","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1696181","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26258788","id":"PMC_26258788","title":"Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin.","date":"2015","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/26258788","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8224164","id":"PMC_8224164","title":"The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins.","date":"1993","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8224164","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28494021","id":"PMC_28494021","title":"Rice black streaked dwarf virus P7-2 forms a SCF complex through binding to Oryza sativa SKP1-like proteins, and interacts with GID2 involved in the gibberellin pathway.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28494021","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19167280","id":"PMC_19167280","title":"Determination of pore-lining residues in the hepatitis C virus p7 protein.","date":"2009","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19167280","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21177929","id":"PMC_21177929","title":"The subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 protein.","date":"2010","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/21177929","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21994720","id":"PMC_21994720","title":"Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy.","date":"2010","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/21994720","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17170445","id":"PMC_17170445","title":"Hepatitis C virus p7 protein is localized in the endoplasmic reticulum when it is encoded by a replication-competent genome.","date":"2007","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/17170445","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25001174","id":"PMC_25001174","title":"The elusive function of the hepatitis C virus p7 protein.","date":"2014","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/25001174","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7548739","id":"PMC_7548739","title":"Specific disulfide formation in the oxidation of HIV-1 zinc finger protein nucleocapsid p7.","date":"1995","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/7548739","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8415682","id":"PMC_8415682","title":"Specificity determinants of the P1 and P7 plasmid centromere analogs.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8415682","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24650428","id":"PMC_24650428","title":"Proteomic analysis of interaction between P7-1 of Southern rice black-streaked dwarf virus and the insect vector reveals diverse insect proteins involved in successful transmission.","date":"2014","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/24650428","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25146005","id":"PMC_25146005","title":"Classical swine fever virus and p7 protein induce secretion of IL-1β in macrophages.","date":"2014","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/25146005","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26355084","id":"PMC_26355084","title":"Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.","date":"2015","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/26355084","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24176102","id":"PMC_24176102","title":"Nonstructural protein P7-2 encoded by Rice black-streaked dwarf virus interacts with SKP1, a core subunit of SCF ubiquitin ligase.","date":"2013","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/24176102","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10809733","id":"PMC_10809733","title":"Inactivation of HIV-1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters. Characterization of reaction products and proposed mechanism of action.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10809733","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10400638","id":"PMC_10400638","title":"Peptide specificity determinants at P-7 and P-6 enhance the catalytic efficiency of Ca2+/calmodulin-dependent protein kinase I in the absence of activation loop phosphorylation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10400638","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28159892","id":"PMC_28159892","title":"Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28159892","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12624058","id":"PMC_12624058","title":"Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients.","date":"2003","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12624058","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22896624","id":"PMC_22896624","title":"Packaging accessory protein P7 and polymerase P2 have mutually occluding binding sites inside the bacteriophage 6 procapsid.","date":"2012","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/22896624","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23246447","id":"PMC_23246447","title":"The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2.","date":"2012","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/23246447","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23271163","id":"PMC_23271163","title":"The secretory pathway and the actomyosin motility system are required for plasmodesmatal localization of the P7-1 of rice black-streaked dwarf virus.","date":"2012","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/23271163","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8573160","id":"PMC_8573160","title":"The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8573160","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24189547","id":"PMC_24189547","title":"Pore-forming activity of pestivirus p7 in a minimal model system supports genus-specific viroporin function.","date":"2013","source":"Antiviral research","url":"https://pubmed.ncbi.nlm.nih.gov/24189547","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23683700","id":"PMC_23683700","title":"Purification, characterisation and expression in Saccharomyces cerevisiae of LipG7 an enantioselective, cold-adapted lipase from the Antarctic filamentous fungus Geomyces sp. P7 with unusual thermostability characteristics.","date":"2013","source":"Enzyme and microbial technology","url":"https://pubmed.ncbi.nlm.nih.gov/23683700","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35659720","id":"PMC_35659720","title":"DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer.","date":"2022","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35659720","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20727848","id":"PMC_20727848","title":"Comparative NMR studies demonstrate profound differences between two viroporins: p7 of HCV and Vpu of HIV-1.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20727848","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10521557","id":"PMC_10521557","title":"DNA damage and DNA damage-inducible protein Gadd45 following ischemia in the P7 neonatal rat.","date":"1999","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10521557","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32223157","id":"PMC_32223157","title":"Assessment of the Multifunctional Behavior of Lupin Peptide P7 and Its Metabolite Using an Integrated Strategy.","date":"2020","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32223157","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12952957","id":"PMC_12952957","title":"Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12952957","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19053279","id":"PMC_19053279","title":"Rrp4 and Csl4 are needed for efficient degradation but not for polyadenylation of synthetic and natural RNA by the archaeal exosome.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19053279","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1459462","id":"PMC_1459462","title":"Transcriptional control via translational repression by c4 antisense RNA of bacteriophages P1 and P7.","date":"1992","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/1459462","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31575882","id":"PMC_31575882","title":"HCV p7 as a novel vaccine-target inducing multifunctional CD4+ and CD8+ T-cells targeting liver cells expressing the viral antigen.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31575882","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3749335","id":"PMC_3749335","title":"Sequence relations among the IncY plasmid p15B, P1, and P7 prophages.","date":"1986","source":"Plasmid","url":"https://pubmed.ncbi.nlm.nih.gov/3749335","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25772504","id":"PMC_25772504","title":"Genotype-specific differences in structural features of hepatitis C virus (HCV) p7 membrane protein.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25772504","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31628467","id":"PMC_31628467","title":"Genetic and genomic studies of pathogenic EXOSC2 mutations in the newly described disease SHRF implicate the autophagy pathway in disease pathogenesis.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31628467","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38445906","id":"PMC_38445906","title":"Identification and characterization of a fungal cutinase-like enzyme CpCut1 from Cladosporium sp. P7 for polyurethane degradation.","date":"2024","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/38445906","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16492760","id":"PMC_16492760","title":"Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16492760","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26193629","id":"PMC_26193629","title":"Complete genome sequence of Clostridium carboxidivorans P7(T), a syngas-fermenting bacterium capable of producing long-chain alcohols.","date":"2015","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/26193629","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23907396","id":"PMC_23907396","title":"Mutations in hepatitis C virus p7 reduce both the egress and infectivity of assembled particles via impaired proton channel function.","date":"2013","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/23907396","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23583663","id":"PMC_23583663","title":"Viroporin activity and membrane topology of classic swine fever virus p7 protein.","date":"2013","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23583663","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12131366","id":"PMC_12131366","title":"A recombinant adenovirus expressing p7(Kip1) induces cell cycle arrest and apoptosis in human 786-0 renal carcinoma cells.","date":"2002","source":"The Journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/12131366","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20488184","id":"PMC_20488184","title":"The evolutionarily conserved subunits Rrp4 and Csl4 confer different substrate specificities to the archaeal exosome.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20488184","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29709564","id":"PMC_29709564","title":"Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin.","date":"2018","source":"Antiviral research","url":"https://pubmed.ncbi.nlm.nih.gov/29709564","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25462337","id":"PMC_25462337","title":"Docking assay of small molecule antivirals to p7 of HCV.","date":"2014","source":"Computational biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25462337","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8224242","id":"PMC_8224242","title":"The antirepressor of phage P1. Isolation and interaction with the C1 repressor of P1 and P7.","date":"1993","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8224242","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8435043","id":"PMC_8435043","title":"Sequence analysis of selected regions of the env (V3 loop and gp41) and gag (p7) reading frames of Ethiopian human immunodeficiency virus type 1 strains.","date":"1993","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/8435043","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11878916","id":"PMC_11878916","title":"Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.","date":"2002","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/11878916","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19175872","id":"PMC_19175872","title":"Reverse genetic analysis of a putative, influenza virus M2 HXXXW-like motif in the p7 protein of hepatitis C virus.","date":"2008","source":"Journal of viral hepatitis","url":"https://pubmed.ncbi.nlm.nih.gov/19175872","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18647606","id":"PMC_18647606","title":"Structure and dynamics of the P7 protein from the bacteriophage phi 12.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18647606","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21604991","id":"PMC_21604991","title":"The influence of different lipid environments on the structure and function of the hepatitis C virus p7 ion channel protein.","date":"2011","source":"Molecular membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/21604991","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26464198","id":"PMC_26464198","title":"Ion channel activity of the CSFV p7 viroporin in surrogates of the ER lipid bilayer.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26464198","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26861619","id":"PMC_26861619","title":"Analysis of uncommon norovirus recombinants from Manaus, Amazon region, Brazil: GII.P22/GII.5, GII.P7/GII.6 and GII.Pg/GII.1.","date":"2016","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26861619","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15060070","id":"PMC_15060070","title":"Characterization of GB virus B polyprotein processing reveals the existence of a novel 13-kDa protein with partial homology to hepatitis C virus p7 protein.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15060070","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23946462","id":"PMC_23946462","title":"Efficiency of E2-p7 processing modulates production of infectious hepatitis C virus.","date":"2013","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/23946462","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32353859","id":"PMC_32353859","title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32353859","citation_count":3411,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6319012","id":"PMC_6319012","title":"Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.","date":"1984","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6319012","citation_count":1545,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21906983","id":"PMC_21906983","title":"Systematic and quantitative assessment of the ubiquitin-modified proteome.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21906983","citation_count":1334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15302935","id":"PMC_15302935","title":"Large-scale characterization of HeLa cell nuclear phosphoproteins.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15302935","citation_count":1159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15635413","id":"PMC_15635413","title":"Nucleolar proteome dynamics.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15635413","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2989703","id":"PMC_2989703","title":"Structural organization of the bcr gene and its role in the Ph' translocation.","date":"1985","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2989703","citation_count":869,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6316147","id":"PMC_6316147","title":"Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia.","date":"1983","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/6316147","citation_count":835,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9390555","id":"PMC_9390555","title":"The exosome: a conserved eukaryotic RNA processing complex containing multiple 3'-->5' exoribonucleases.","date":"1997","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9390555","citation_count":807,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11719186","id":"PMC_11719186","title":"AU binding proteins recruit the exosome to degrade ARE-containing mRNAs.","date":"2001","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11719186","citation_count":736,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1538749","id":"PMC_1538749","title":"Sequence identification of 2,375 human brain genes.","date":"1992","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1538749","citation_count":708,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33060197","id":"PMC_33060197","title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33060197","citation_count":564,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3021337","id":"PMC_3021337","title":"Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.","date":"1986","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/3021337","citation_count":476,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17174896","id":"PMC_17174896","title":"Reconstitution, activities, and structure of the eukaryotic RNA exosome.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17174896","citation_count":449,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15687258","id":"PMC_15687258","title":"Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1.","date":"2005","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15687258","citation_count":410,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10465791","id":"PMC_10465791","title":"The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10465791","citation_count":390,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45976,"output_tokens":1471,"usd":0.079996},"stage2":{"model":"claude-opus-4-6","input_tokens":4389,"output_tokens":1543,"usd":0.09078},"total_usd":0.426232,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":57319,"output_tokens":3553,"usd":0.112626},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6524,"output_tokens":2504,"usd":0.14283}},"stage1_raw":"Looking at the corpus, I need to identify papers about EXOSC2 (also known as RRP4, a core component of the RNA exosome complex). Most papers in this corpus are about HCV p7, HIV p7/NC, bacteriophage P7, or other unrelated \"P7\" entities. I can identify only two papers genuinely about EXOSC2/RRP4:\n\n- PMID 26843489: Clinical/genetic paper describing EXOSC2 mutations causing a syndrome, noting EXOSC2 encodes RRP4, a core component of the RNA exosome.\n- PMID 31628467: Mechanistic study of EXOSC2/RRP4 pathogenic mutations in patient lymphoblasts, CRISPR models, and Drosophila.\n\nAlso relevant are papers about archaeal exosome Rrp4 (EXOSC2 ortholog):\n- PMID 19053279: Biochemical characterization of archaeal Rrp4 exosome\n- PMID 20488184: Substrate specificity of Rrp4 vs Csl4 in archaeal exosome\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"EXOSC2 (encoding RRP4) is a core structural component of the RNA exosome multiprotein complex, which plays key roles in RNA processing and degradation; biallelic missense mutations in EXOSC2 cause a novel syndrome (SHRF) with retinitis pigmentosa, hearing loss, premature ageing, short stature, and intellectual disability, establishing that EXOSC2 function is essential for normal development across multiple tissues.\",\n      \"method\": \"Whole exome sequencing of affected patients combined with molecular identification of EXOSC2 as an RNA exosome core component\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic identification in patients, but no direct in vitro reconstitution or epistasis in this paper; single cohort\",\n      \"pmids\": [\"26843489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The pathogenic EXOSC2 G198D missense mutation prevents binding of EXOSC2 to other RNA exosome components, resulting in protein and complex instability; EXOSC2 is an essential gene, and its loss leads to altered expression and activity of autophagy pathway genes (ATG1, ATG17) regulated by MITF; pharmacological stimulation of autophagy with rapamycin rescued lethality caused by rrp4 (EXOSC2 ortholog) inactivation in Drosophila, and wild-type human EXOSC2 but not the G198D pathogenic form rescued fly rrp4 phenotypes.\",\n      \"method\": \"Patient-derived lymphoblast analysis, CRISPR-generated mutant human keratinocytes, Drosophila rrp4 knockout/RNAi models, co-immunoprecipitation to assess complex assembly, rapamycin rescue experiments\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP showing disrupted complex assembly, CRISPR KO, Drosophila genetics, pharmacological rescue) in a single study with rigorous controls\",\n      \"pmids\": [\"31628467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The archaeal EXOSC2 ortholog Rrp4 (within the Sulfolobus solfataricus exosome) is required for efficient RNA degradation but not for polyadenylation; the Rrp4-containing exosome complex promotes phosphorolysis of substrates that the catalytic hexameric ring alone cannot efficiently degrade, indicating Rrp4 enhances substrate binding and delivery to the active site.\",\n      \"method\": \"In vitro biochemical reconstitution assays comparing hexameric ring, Rrp4-exosome, and Csl4-exosome activities on defined RNA substrates under varying conditions\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method (in vitro reconstitution) but archaeal ortholog, single study\",\n      \"pmids\": [\"19053279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The archaeal EXOSC2 ortholog Rrp4 confers a distinct substrate specificity to the exosome compared to the paralogous cap subunit Csl4: the Rrp4-exosome strongly prefers poly(A) RNA substrates, while the Csl4-exosome more efficiently degrades A-poor 3'-end RNA; both subunits negatively respond to high C-content and polyuridylated substrates.\",\n      \"method\": \"In vitro RNA degradation assays with reconstituted archaeal exosome complexes of defined composition on defined RNA substrates\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method (in vitro reconstitution with defined substrates) but archaeal ortholog, single study\",\n      \"pmids\": [\"20488184\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EXOSC2 (RRP4) is an essential cap subunit of the RNA exosome complex whose primary mechanistic role is to bind other exosome components and facilitate efficient RNA degradation by enhancing substrate recruitment to the catalytic ring; pathogenic missense mutations (e.g., G198D) disrupt binding to partner exosome subunits, destabilizing the complex and impairing RNA metabolism, with downstream consequences including dysregulation of the autophagy pathway via MITF-regulated genes.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nLooking at the corpus, I need to identify papers about EXOSC2 (also known as RRP4/hRrp4, a core component of the RNA exosome complex).\n\n**Classification:**\n\nFrom the 100 retrieved papers: Nearly all are about HCV p7, HIV p7/NCp7, bacteriophage P7, plant virus P7, or other unrelated \"P7\" entities. These are ALIAS COLLISION / SYMBOL COLLISION cases — EXCLUDE all.\n\nFrom the 30 gene2pubmed-curated papers:\n- PMID:26843489 — EXOSC2 mutations, novel syndrome SHRF — KEEP\n- PMID:31628467 — EXOSC2/RRP4 pathogenic mutations, mechanism — KEEP\n- PMID:9390555 — Original exosome discovery, hRrp4 (EXOSC2 ortholog) identified — KEEP\n- PMID:17174896 — Reconstitution + structure of eukaryotic RNA exosome including human Rrp4 — KEEP\n- PMID:10465791 — Yeast exosome + human PM-Scl, Rrp4p homolog — KEEP\n- PMID:11719186 — Human exosome purified, ARE-mediated decay — KEEP\n- PMID:22658674 — mRNA interactome (EXOSC2 identified as RBP) — KEEP (mechanistic finding)\n- PMID:15687258 — TTP/BRF-1 recruit exosome — KEEP\n- PMID:15635413 — Nucleolar proteome, exosome dynamics — KEEP (localization)\n- PMID:19053279 — Archaeal exosome, Rrp4 role — KEEP (ortholog)\n- PMID:20488184 — Rrp4 vs Csl4 substrate specificity — KEEP (ortholog)\n- Remaining papers (BioPlex, BCR, cDNA sequences, interactome maps, ubiquitin proteome, phosphoproteome, etc.) — these are large-scale datasets where EXOSC2 appears incidentally; no mechanistic findings specific to EXOSC2 — EXCLUDE from discovery extraction.\n- PMID:32353859, PMID:33060197 — SARS-CoV-2 interactome; EXOSC2 may appear but no specific mechanistic finding — EXCLUDE\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"EXOSC2 (hRrp4/Rrp4p) was identified as a core component of the eukaryotic RNA exosome, a conserved multisubunit complex. Yeast Rrp4p (the ortholog of human EXOSC2) was shown to be an essential 3'→5' exoribonuclease required for 3' processing of 5.8S rRNA. Recombinant Rrp4p exhibited distributive 3'→5' exoribonuclease activity in vitro, and human hRRP4 was found in a comparably sized complex to the yeast exosome, with expression of hRRP4 complementing the yeast rrp4-1 mutation.\",\n      \"method\": \"Biochemical purification, in vitro exoribonuclease assay, genetic complementation (hRRP4 rescuing yeast rrp4-1)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic reconstitution plus genetic complementation, foundational discovery paper with >800 citations\",\n      \"pmids\": [\"9390555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The human homolog of yeast Rrp4p (EXOSC2) was confirmed as a component of the human PM-Scl complex (equivalent to the yeast exosome). The human exosome exists in distinct nuclear and cytoplasmic forms; the nuclear form uniquely contains Rrp6p/PM-Scl100. Human Rrp4p (EXOSC2) was shown to complement the yeast rrp4 mutation, establishing functional conservation. The complex contains multiple predicted 3'→5' exoribonucleases.\",\n      \"method\": \"Biochemical fractionation, indirect immunofluorescence, genetic complementation, sequence homology analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — complementation plus biochemical fractionation plus localization, replicated across yeast and human systems\",\n      \"pmids\": [\"10465791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The human RNA exosome (containing EXOSC2/hRrp4 as a core subunit) was purified by mass spectrometry and shown to be required for rapid degradation of ARE-containing mRNAs in a cell-free RNA decay system. The exosome does not recognize ARE-containing RNAs autonomously; ARE-binding proteins (such as KSRP) interact with the exosome and recruit it to unstable target mRNAs.\",\n      \"method\": \"Affinity purification/mass spectrometry of human exosome, cell-free RNA decay assay, immunodepletion\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — cell-free reconstitution of decay activity with immunodepletion controls, multiple orthogonal methods\",\n      \"pmids\": [\"11719186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The ARE-binding proteins TTP and BRF-1 recruit the RNA exosome (which contains EXOSC2 as a core subunit) to ARE-containing mRNAs via two distinct activation domains. The N-terminal activation domain of TTP functions as a binding platform for mRNA decay enzymes including the exosome, linking ARE-mRNAs to 3'→5' exonucleolytic decay.\",\n      \"method\": \"Co-immunoprecipitation, tethering assays with heterologous RNA-binding domain fusions, dominant-negative overexpression\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interactions confirmed with multiple functional assays and dominant-negative validation\",\n      \"pmids\": [\"15687258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The 9-subunit human RNA exosome (including EXOSC2/hRrp4) was reconstituted recombinantly and its X-ray crystal structure was determined at 3.35 Å resolution. Human Rrp41/Rrp45 heterodimer displayed processive phosphorolytic 3'→5' exoribonuclease activity, while the intact 9-subunit human exosome also showed processive phosphorolytic activity on AU-rich, poly(A), and generic RNA substrates. The structure revealed the conserved barrel-like architecture with EXOSC2 (Rrp4) as a cap subunit on the ring.\",\n      \"method\": \"Recombinant protein reconstitution, X-ray crystallography (3.35 Å), in vitro exoribonuclease assay with multiple RNA substrates\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus reconstituted biochemical activity with comparative analysis across multiple subunit compositions\",\n      \"pmids\": [\"17174896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"EXOSC2 (hRrp4) was detected as part of the nucleolar proteome in human cells and was shown to flux out of the nucleolus in response to metabolic inhibitors (actinomycin D, 5-fluorouridine, RNase inhibitor), consistent with a role in nucleolar RNA processing. The exosome components including EXOSC2 exit the nucleolus with similar kinetics, indicating stable complex association.\",\n      \"method\": \"SILAC-based quantitative mass spectrometry of nucleolar proteome, in vivo fluorescent protein imaging, metabolic inhibitor treatment\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative proteomics with functional perturbation, but localization study without direct mechanistic follow-up for EXOSC2 specifically\",\n      \"pmids\": [\"15635413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The archaeal exosome cap subunit Rrp4 (ortholog of human EXOSC2) from Sulfolobus solfataricus is required for efficient RNA degradation but not for polyadenylation by the hexameric catalytic ring. The Rrp4-containing exosome (versus the hexamer alone) enables efficient phosphorolytic degradation of substrates that the hexamer cannot efficiently process alone, demonstrating that the RNA-binding cap confers substrate accessibility to the catalytic core.\",\n      \"method\": \"In vitro reconstitution of archaeal exosome subcomplexes, RNA degradation and polyadenylation assays with varied substrates and conditions\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with multiple substrate types and systematic comparison of subunit compositions\",\n      \"pmids\": [\"19053279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The archaeal Rrp4-containing exosome (ortholog of EXOSC2) confers a strong preference for poly(A) RNA substrates, whereas the Csl4-containing exosome prefers A-poor 3'-ends. This demonstrates that the two cap subunits (Rrp4 and Csl4) impart distinct substrate specificities to the same catalytic ring, establishing that EXOSC2/Rrp4 specifically promotes processing of polyadenylated RNA targets.\",\n      \"method\": \"In vitro RNA processing assays with reconstituted archaeal exosome subcomplexes containing either Rrp4 or Csl4, using poly(A), polyU, and heteropolymeric RNA substrates\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with defined subunit compositions and systematic substrate variation\",\n      \"pmids\": [\"20488184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Biallelic missense mutations in EXOSC2 (encoding the RRP4 cap subunit of the RNA exosome) cause a novel human Mendelian syndrome (SHRF) characterized by retinitis pigmentosa, progressive sensorineural hearing loss, premature ageing, short stature, brachydactyly, and mild intellectual disability. Three patients from two unrelated families carried homozygous or compound heterozygous EXOSC2 missense variants, implicating altered RNA exosome function in the pathogenesis and demonstrating tissue-specific consequences distinct from other exosome subunit diseases (EXOSC3, EXOSC8).\",\n      \"method\": \"Whole exome sequencing, clinical ascertainment of three affected individuals from two unrelated families\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic identification of pathogenic variants without direct molecular mechanism characterization in this paper\",\n      \"pmids\": [\"26843489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The SHRF-associated pathogenic G198D mutation in EXOSC2 prevents binding to other RNA exosome components, resulting in protein and complex instability. Patient-derived lymphoblasts and CRISPR-generated mutant fetal keratinocytes showed altered expression/activities of critical genes including those in the autophagy pathway. In Drosophila, the fly rrp4 ortholog was shown to be essential; fly rrp4 phenotypes (small eye, adult lethality) could be rescued by wild-type human EXOSC2 but not the G198D pathogenic form. Overexpression of MITF transcription factor, or the autophagy genes ATG1 and ATG17 (regulated by MITF), rescued rrp4 inhibition phenotypes. Pharmacological stimulation of autophagy with rapamycin also rescued lethality caused by rrp4 inactivation.\",\n      \"method\": \"Patient-derived lymphoblast analysis, CRISPR knockout in fetal keratinocytes, Drosophila genetics (PBac transposon, RNAi, CRISPR KO), cross-species rescue experiments, rapamycin pharmacological rescue\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including cross-species genetic rescue, pathogenic mutation functional validation, and pharmacological rescue converging on autophagy pathway\",\n      \"pmids\": [\"31628467\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EXOSC2 (hRrp4) functions as an essential cap subunit of the RNA exosome, a conserved multisubunit 3'→5' exoribonuclease complex; it confers substrate specificity (preferentially enabling processing of polyadenylated RNAs) to the catalytic ring, is required for 5.8S rRNA 3'-processing and ARE-mediated mRNA decay (via recruitment by ARE-binding proteins such as TTP), localizes to both nuclear/nucleolar and cytoplasmic exosome pools, and its pathogenic missense mutations (e.g., G198D causing SHRF syndrome) disrupt binding to other exosome subunits leading to complex instability and defective autophagy pathway regulation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"EXOSC2 (RRP4) is a cap subunit of the RNA exosome complex that enhances substrate recruitment and delivery to the catalytic hexameric ring, conferring preference for poly(A) RNA substrates during phosphorolytic degradation [PMID:19053279, PMID:20488184]. The pathogenic G198D missense mutation disrupts EXOSC2 binding to other exosome subunits, destabilizing the complex and impairing RNA metabolism, with downstream dysregulation of MITF-regulated autophagy genes (ATG1, ATG17); pharmacological activation of autophagy by rapamycin rescues lethality caused by EXOSC2 ortholog loss in Drosophila [PMID:31628467]. Biallelic missense mutations in EXOSC2 cause a multisystem syndrome (SHRF) featuring retinitis pigmentosa, hearing loss, premature ageing, short stature, and intellectual disability [PMID:26843489].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"It was unknown whether the cap subunit Rrp4 (EXOSC2 ortholog) contributes catalytically or acts as a substrate-delivery factor; reconstitution showed it enhances phosphorolytic degradation of RNAs that the hexameric ring alone processes poorly, establishing Rrp4 as an essential enhancer of substrate binding rather than a catalytic subunit.\",\n      \"evidence\": \"In vitro biochemical reconstitution of archaeal exosome complexes with and without Rrp4 on defined RNA substrates\",\n      \"pmids\": [\"19053279\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Archaeal ortholog—transferability to human EXOSC2 not directly tested\",\n        \"Structural basis for how Rrp4 promotes substrate engagement unresolved\",\n        \"No in vivo validation of the substrate-delivery model\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Whether different cap subunits confer distinct RNA substrate preferences was unknown; reconstitution revealed that Rrp4-containing exosomes strongly prefer poly(A) substrates while Csl4-containing exosomes prefer A-poor RNAs, establishing that EXOSC2/Rrp4 shapes exosome substrate selectivity.\",\n      \"evidence\": \"In vitro degradation assays with reconstituted archaeal exosome complexes of defined subunit composition on varied RNA substrates\",\n      \"pmids\": [\"20488184\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Archaeal system—human exosome substrate specificity determinants not tested\",\n        \"Whether poly(A) preference translates to in vivo target selection unknown\",\n        \"Structural determinants of substrate discrimination not mapped\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The in vivo essentiality of EXOSC2 in humans was unestablished; exome sequencing identified biallelic EXOSC2 missense mutations as the cause of a novel multisystem developmental syndrome (SHRF), demonstrating that EXOSC2 is required for normal development across retinal, auditory, skeletal, and neuronal tissues.\",\n      \"evidence\": \"Whole exome sequencing of affected patients with Mendelian filtering and candidate gene prioritization\",\n      \"pmids\": [\"26843489\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single patient cohort without functional validation of pathogenic mechanism\",\n        \"Tissue-specific vulnerability mechanisms unexplained\",\n        \"No demonstration of how mutations affect exosome assembly or RNA processing\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"How pathogenic EXOSC2 mutations impair molecular function was unknown; co-immunoprecipitation, CRISPR editing, and Drosophila models showed that the G198D mutation prevents EXOSC2 from binding exosome partners, destabilizes the complex, dysregulates autophagy via MITF-dependent genes, and that rapamycin-stimulated autophagy rescues lethality, linking exosome integrity to autophagy regulation.\",\n      \"evidence\": \"Co-immunoprecipitation in patient lymphoblasts and CRISPR-edited keratinocytes; Drosophila rrp4 knockout/RNAi with human transgene rescue; rapamycin treatment\",\n      \"pmids\": [\"31628467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct RNA targets of EXOSC2-containing exosome in human cells not profiled\",\n        \"Mechanism linking exosome disruption to MITF-dependent autophagy gene regulation not fully delineated\",\n        \"Whether autophagy dysregulation explains all disease-relevant tissue pathologies is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct RNA substrates of the human EXOSC2-containing exosome, the structural basis of the G198D binding defect, and the precise mechanism by which exosome disruption leads to MITF-dependent autophagy dysregulation remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No transcriptome-wide identification of human EXOSC2-dependent RNA targets\",\n        \"No high-resolution structural data for wild-type vs. G198D human EXOSC2 within the exosome\",\n        \"Tissue-specific pathology mechanisms in SHRF syndrome unexplained\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [\"RNA exosome\"],\n    \"partners\": [\"MITF\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"EXOSC2 (RRP4) is an essential cap subunit of the RNA exosome, a conserved multisubunit 3'→5' exoribonuclease complex that mediates processing and degradation of diverse RNA substrates. EXOSC2 sits atop the hexameric catalytic ring and confers substrate specificity, preferentially directing the complex toward polyadenylated RNA targets, while also enabling efficient substrate access to the catalytic core for phosphorolytic degradation [PMID:9390555, PMID:17174896, PMID:20488184]. The exosome containing EXOSC2 is recruited to AU-rich element (ARE)-containing mRNAs by RNA-binding proteins such as TTP and KSRP, coupling it to rapid cytoplasmic mRNA turnover, and it functions in nucleolar 5.8S rRNA 3'-end processing [PMID:11719186, PMID:15687258, PMID:15635413]. Biallelic missense mutations in EXOSC2 cause SHRF syndrome (retinitis pigmentosa, hearing loss, premature ageing, short stature, brachydactyly, and mild intellectual disability); the pathogenic G198D variant disrupts exosome subunit binding, destabilizes the complex, and deregulates autophagy, with autophagy stimulation rescuing loss-of-function phenotypes in Drosophila [PMID:26843489, PMID:31628467].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"The discovery that Rrp4p is an essential 3'→5' exoribonuclease subunit of the yeast exosome complex — and that human EXOSC2 complements the yeast mutation — established the conserved role of this gene in RNA processing and defined the exosome as a multisubunit degradation machine.\",\n      \"evidence\": \"Biochemical purification, in vitro exoribonuclease assay, and cross-species genetic complementation in yeast\",\n      \"pmids\": [\"9390555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EXOSC2 itself contributes catalytic activity or solely serves a structural/substrate-channeling role in the human complex was unresolved\", \"Identity of in vivo RNA substrates beyond 5.8S rRNA unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstration that the human exosome exists in distinct nuclear and cytoplasmic pools, with EXOSC2 present in both, revealed compartment-specific functions and linked the complex to the PM-Scl autoantigen.\",\n      \"evidence\": \"Biochemical fractionation and indirect immunofluorescence in human cells\",\n      \"pmids\": [\"10465791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EXOSC2 has compartment-specific roles beyond shared core membership was not addressed\", \"Mechanism of nuclear versus cytoplasmic sorting of exosome subcomplexes undefined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The finding that the human exosome is required for ARE-mediated mRNA decay — recruited by ARE-binding proteins rather than recognizing substrates autonomously — placed EXOSC2-containing complexes at the center of regulated mRNA turnover.\",\n      \"evidence\": \"Affinity-purified human exosome tested in cell-free ARE-RNA decay assay with immunodepletion controls\",\n      \"pmids\": [\"11719186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct contact between EXOSC2 and ARE-binding adaptors was not mapped\", \"Relative contributions of individual cap subunits to adaptor recruitment unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of TTP and BRF-1 activation domains as direct exosome-recruiting interfaces provided a molecular mechanism for how ARE-containing mRNAs are coupled to 3'→5' exonucleolytic decay via the EXOSC2-containing complex.\",\n      \"evidence\": \"Co-immunoprecipitation and tethering assays with heterologous RNA-binding domain fusions, dominant-negative overexpression\",\n      \"pmids\": [\"15687258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EXOSC2 is the direct binding partner for TTP/BRF-1 or whether another subunit mediates the interaction was not determined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The crystal structure of the reconstituted 9-subunit human exosome at 3.35 Å resolution revealed the barrel-like architecture with EXOSC2 as a cap subunit and demonstrated processive phosphorolytic activity of the ring, resolving the structural framework for substrate channeling.\",\n      \"evidence\": \"Recombinant reconstitution and X-ray crystallography of the human exosome complex\",\n      \"pmids\": [\"17174896\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure did not resolve how RNA threads through the cap into the catalytic channel at high resolution\", \"Human-specific regulatory contacts of EXOSC2 not detailed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Reconstitution of archaeal exosomes containing either Rrp4 or Csl4 cap subunits showed that the Rrp4 cap (EXOSC2 ortholog) confers a strong preference for poly(A) substrates, establishing that individual cap subunits dictate substrate specificity of the catalytic ring.\",\n      \"evidence\": \"In vitro RNA processing assays with defined archaeal exosome subcomplexes and systematic substrate variation\",\n      \"pmids\": [\"20488184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the poly(A) preference of Rrp4/EXOSC2 is conserved in the eukaryotic 9-subunit context was not directly tested\", \"Structural basis of poly(A) selectivity at the Rrp4 S1/KH domains unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Whole-exome sequencing linked biallelic EXOSC2 missense mutations to SHRF syndrome, a previously unrecognized Mendelian disorder, demonstrating that partial loss of this exosome cap subunit produces tissue-specific pathology distinct from diseases caused by mutations in other exosome subunits.\",\n      \"evidence\": \"Whole-exome sequencing in three patients from two unrelated families\",\n      \"pmids\": [\"26843489\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism by which the mutations compromise exosome function was not characterized in this study\", \"Why EXOSC2 mutations produce a different clinical spectrum than EXOSC3/EXOSC8 mutations remained unexplained\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Functional characterization of the SHRF-associated G198D mutation revealed that it disrupts EXOSC2 binding to other exosome subunits, destabilizes the complex, and deregulates autophagy-related gene expression; pharmacological or genetic restoration of autophagy rescued loss-of-function phenotypes, identifying autophagy as a critical downstream effector of exosome integrity.\",\n      \"evidence\": \"Patient lymphoblasts, CRISPR mutant keratinocytes, Drosophila cross-species rescue experiments, and rapamycin pharmacological rescue\",\n      \"pmids\": [\"31628467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether autophagy deregulation is a direct consequence of specific RNA misprocessing or a secondary stress response is unclear\", \"The EXOSC2-dependent RNA targets whose misprocessing drives the SHRF phenotype have not been identified transcriptome-wide\", \"Whether rapamycin-based autophagy stimulation is a viable therapeutic strategy in SHRF patients is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of specific RNA substrates whose processing depends on the EXOSC2 cap (versus the EXOSC1/Csl4 cap) in human cells, the structural basis for poly(A) selectivity by the EXOSC2 S1/KH domains in the eukaryotic context, and why EXOSC2 mutations produce a tissue-specific disease spectrum (retina, cochlea, skeleton) despite the exosome's ubiquitous expression.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No transcriptome-wide identification of EXOSC2-cap-dependent versus EXOSC1-cap-dependent substrates in human cells\", \"No high-resolution structure of EXOSC2 with RNA threaded through the channel in the eukaryotic context\", \"Tissue-specific vulnerability mechanism for SHRF syndrome unexplained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 4, 6, 7]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 6, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 2, 3, 6, 7]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [\"RNA exosome\"],\n    \"partners\": [\"EXOSC4\", \"EXOSC7\", \"TTP\", \"KSRP\", \"BRF1\"],\n    \"other_free_text\": []\n  }\n}\n```"}